Together we will beat cancer

Donate

Routes to a healthier shopping journey – how your supermarket environment influences what goes into your basket

In partnership with British Heart Foundation and Diabetes UK, we have released our new Trolley Trends analysis which explores attitudes and behaviours around healthy eating and food shopping

Read More

“Nothing about us without us”: Why we’re working in partnership with other leading health organisations on the Shared Commitment to Public Involvement

One year on from signing up to the Shared Commitment to Patient Involvement, we’re reflecting on our successes in involving people affected by cancer in research, but also on where we strive to do better.

Read More

Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

Read More

Tesco is making it even easier to support life-saving research

Since 2018, Tesco, Cancer Research UK, Diabetes UK and the British Heart Foundation have been working together to change lives….

Read More

Celebrating 10 years of partnership with NIVEA Sun

This year, we wanted to show our deep appreciation to NIVEA Sun who have supported Cancer Research UK for the…

Read More

Pharmacy services are an untapped resource in tackling nation’s major health conditions, new survey reveals

A new YouGov survey has revealed that just 1 in 10 people have turned to their local pharmacy for advice…

Read More

Sustainability a major focus of our 17th year partnering with TK Maxx

In 2004, we joined forces with TK Maxx to raise awareness and funds for children’s and young people’s cancers. Since…

Read More

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

Read More

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

Read More

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

Read More